Similarly, cyclin D1 can be exploitable as a diagnostic adjunct marker to be used in combination with the conventional immunomarkers CD99 and NB84, to confirm the diagnosis of EWS or NB on small biopsies, respectively. This evidence concerns the gene CCND1 and neuroblastoma.